More Than 112 Years of Dedicated Service to Mankind
CLINICAL PATHOLOGY
INTRODUCTION | TRAINING | RESEARCH | TESTING FACILITIES | TEAM | PUBLICATION

Research - Department Projects

1. Identification of ligand-receptor interactions across blood brain barrier in viral neuro-pathogenesis (EXTRA-MURAL Funding)

Team: Dr. Shashikant Vaidya (P.I.) & Ms. Durga Bethala (DST-INSPIRE-SRF)

Funding Agency: Department of Science and Technology, Govt. of India

Duration: March 2017 - Till date

Abstract:
More than 500 million people worldwide are infected each year by any of the four dengue virus (DENV) serotypes. Dengue serotype 2 (DENV 2) is most predominant in India and other South Asian countries. The clinical spectrum caused during dengue infections is wide, and some patients may develop neurological alterations during or after infection. Clinical evidence suggests that the blood-brain barrier (BBB) may be compromised during DENV infection; however, it is unclear whether the damage is due to the infection itself or to the inflammatory response activated by BBB cells. Other neurotropic flaviviruses, such as Japanese encephalitis virus (JEV), are also known to cause neurological damage. JEV uses the bloodstream to enter nerve tissue, infecting cells of the neurovascular unit. Another neurotropic virus, rabies virus (RABV), uses the retrograde axonal route to infect neuronal cells. Both JEV and RABV affect neurovascular unit cells differently, resulting in BBB damage, glial activation, and tissue inflammation. The aim of this project is to study the pattern of DENV infection in the BBB, compared with other neurotropic viruses like JEV and RABV using an in vitro model. Our study observed that the BBB is dysregulated by superinfecting DENV2-activated murine macrophages (RAW264.7) on murine endothelial cells (BEnd3), rather than by direct virus infection.

2. Quantitative phosphoproteome profiling of circulating influenza virus strains in Mumbai region

Team: Dr. Shashikant Vaidya (P.I.) & Ph.D. Student Ms. Pinky Singh

Funding Agency: Haffkine Institute

Duration: December 2017 - January 2025

Abstract:
Influenza viruses are major human pathogens whose genotypic diversity results in unpredictable pandemics and epidemics. Although annual influenza epidemics affect around 10% of the global population, current treatment options are limited, and development of new antivirals is needed. Elucidation of host factors required during virus infection provides information on signaling pathways involved and the identification of novel drug targets. Quantitative phosphoproteomics will help reveal the unique phosphoproteome dynamics occurring in host cells within minutes of influenza virus infection. In this study, influenza virus isolates will be subjected to PCR for amplification of gene sequences according to WHO primer pairing to quantify relative viral load. Quantitative phosphoproteomic analysis of human lung carcinoma epithelial cell line (A549) infected with influenza viruses will be performed at varying time intervals. Harvested cells will be analyzed using TEM and flow-based studies, followed by iTRAQ labeling. Identification and quantitative analysis of iTRAQ-labeled phosphopeptides will be performed using LC-MS/MS.

© Copyright Haffkine Institute for Training, Research and Testing - Designed & Developed By Visual Ventures 
Legal Notices | Privacy Policy  
Logo Significance